Medical Research Council, UK
2017-2020, R Spiller, A Emmanuel, P Whorwell, M Scott, Phil Dinning, A Ford, A Farmer, et al, Project: Novel diagnostics and treatments for Irritable Bowel Syndrome, $3,716,909 AUD (£2,323,053.94).
2016-2018, R Spiller, L Marciani, P Gowland, G Major, G Moran, M Scott, C Knowles, C Hoad, S Taylor, A Emmanuel, C Coupland, Phil Dinning, Project: The causes of constipation. Reclassifying constipation using MRI and high resolution manometry to define mechanism of disease and target treatment,$2,520,826 AUD (£1,244,902).
Stiftelsen Olle Engqvist Byggmästare (admin through Uppsala University, Sweden)
2017-2018, Karin Nordstrom and Shannon Olsson (NCBS), Project: Multi-modal factors involved in hoverfly pollination: Behaviour and neural coding,$140,000 AUD.
Ironwood Pharmaceuticals Inc
2017, Stuart Brierley, Project: Investigating the mechanisms of action of Linaclotide on colonic and bladder afferent pathways, $220,000.
Motor Neuron Disease Research Institute
2017, Mary-Louise Rogers, Project: CSF and serum p75 extracellular domain as validation of a fluid biomarker for MND, $94,925.
World Cancer Research Fund International
2016-2019, Janni Petersen, Project: Characterisation of TORC1 control of AMPK activity, $392,440.
Health Research Council, NZ
2016-2019, G O’Grady, I Bissett, L Cheng, P Du, N Paskaranandavadivel, C Stinear, Phil Dinning. Project: Mechanistic, Diagnostic and Therapeutic Advances in Fecal Incontinence and Anterior Resection Syndrome, $1,133,353 AUD ($1,200,000 NZ).
National Institute of Health
2014-2019, Mary-Louise Rogers, Project: Clinical research in ALS and related disorders for therapeutic development (Lead: Uni Miami),$63,346.